Navigation Links
Detecting 'bath salts' designer drug
Date:10/18/2011

HUNTSVILLE, TX -- In October 2011 the National Institute of Justice (NIJ) and the Forensic Science Foundation (FSF) funded a capstone project proposal in the Master of Forensic Science Program at Sam Houston State University to investigate the designer drugs known as "Bath Salts" (beta-keto-amphetamines or BKAs).

Designer drugs have posed a challenge for law enforcement and forensic scientists for decades, but more recently the proliferation of analogs has overwhelmed the scientific community, in large part due to the internet. The majority of BKA designer drugs are derived from cathinone, the active ingredient of Khat (Catha edulis), a plant native to Africa and the Middle East. Synthesis of these drugs is readily accomplished by clandestine chemists, making it an appealing drug for the designer drugs market.

The study will specifically address a number of central nervous system stimulants that are capable of producing powerful and unpredictable adrenergic and hallucinogenic effects. Many of these drugs were considered "legal highs" until the Drug Enforcement Administration placed several of them in Schedule I of the Federal Controlled Substance Act in an emergency scheduling action earlier this year. These drugs were available locally in gas stations, head shops and online until September 1 of this year, when The State of Texas enacted legislation to ban these substances. At least 24 other states have outlawed them, or have legislation pending due to intense media interest and publicity.

In the SHSU study, at least six of the most popular "bath salt" drugs will be investigated in biological samples. These include mephedrone, methylone, ethylone, butylone, MDPV and naphyrone. Mephedrone is one of the most common BKAs. It has a reputation of having similar but superior effects to MDMA (3,4 -methylenedioxymethamphetamine or Ecstasy). Street names for mephedrone include MCAT, meow meow, MMC hammer, 4 MMC, bubbles, meph, rush, drone and plant feeder. Mephedrone and the related BKAs are still relatively new, so few clinical, pharmacological or toxicological studies have been reported.

These drugs are easily identified in seized drug materials. The SHSU Regional Crime Laboratory (RCL), operated by the Criminal Justice Center, routinely receives items of evidence containing these drugs. Detection in toxicological (biological) evidence is far more challenging. Toxicologists are struggling to develop methodology to detect these drugs (and their metabolites) in biological specimens. Even less is understood with respect to the interpretation of results, and this has real consequences in terms of criminal casework and death investigation.

In order for these drugs to be studied and understood, analytical methodology will be developed for routine use. In the study, solid phase extraction (SPE) will be used to isolate the beta-keto amphetamines from biological matrices. Chromatographic and spectroscopic methods will be developed for instrumental analysis of the biological extracts. Chemical derivatization will be used to develop extracts that are amenable to common instrumental techniques that are used in a crime laboratory, such as gas chromatography/mass spectrometry (GC/MS).

The study, which will be conducted by MSFS student Kayla Ellefsen and Dr. Sarah Kerrigan at RCL, is an example of the MSFS student capstone experience, whereby students must successfully complete an intensive one-year research project with a faculty member. During the final phase of the study, the optimized procedure will be validated for use in actual casework at the lab.


'/>"/>

Contact: Beth Kuhles
kuhles@sbcglobal.net
936-294-4425
Sam Houston State University
Source:Eurekalert

Related medicine news :

1. Study: Mechanomyography to be accurate in detecting nerves during minimally invasive spine surgery
2. FDG-PET/CT plays a definite role in detecting colorectal cancer recurrences
3. Detecting tumors faster
4. Sodium MRI gives new insights into detecting osteoarthritis, NYU researchers find
5. Effective methods for detecting early signs of tremor
6. Colorful brains, cooling lasers, disease-detecting lights and more
7. deCODE discovers genetic markers that improve the power of PSA testing for detecting prostate cancer
8. Detecting esophageal cancer with light
9. New molecular imaging technologies for detecting cellular processes
10. Toward a fast, simple test for detecting cholera rampaging in 40 countries
11. Penn study suggests another avenue for detecting Alzheimers disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/23/2017)... ... August 23, 2017 , ... Based on ... safety and efficacy of HBOT in treating and helping to heal addictions and ... research showing the similarities of the wounds to the brain from traumatic brain ...
(Date:8/23/2017)... , ... August 23, 2017 , ... ... healthcare industry, made the 2017 Inc. 5000 with a three-year sales growth ... nation’s fastest-growing private companies and comprises the most comprehensive look at America’s independent ...
(Date:8/23/2017)... ... 2017 , ... MobilityWorks ®, the nation's largest retailer ... Inc. 500|5000, an exclusive ranking of America’s fastest-growing private companies. MobilityWorks (aka WMK) ... the twelfth year that the company has been included on the list. , ...
(Date:8/23/2017)... , ... August 23, 2017 , ... ... the American Academy of Orthopaedic Surgeons , points out that therapeutic modalities ... from pain or injury. According to the report, a wider scope of physical ...
(Date:8/22/2017)... ... August 22, 2017 , ... The old adage ... as simple as eating healthy foods. But this well-known piece of nutrition advice ... or breaking apart carbohydrates—depends not only on properties of the food but also ...
Breaking Medicine News(10 mins):
(Date:8/8/2017)... 2017   Second-quarter ... (GAAP) loss per share from continuing operations ... increased 16 percent to $110 million ... percent to $161 million ... continuing operations increased 8 percent to $0.93 ...
(Date:8/7/2017)... Aug. 7, 2017 Zimmer Biomet Holdings, Inc. (NYSE ... announced that its Board of Directors has approved the payment ... quarter of 2017. The ... or about October 27, 2017 to stockholders of record as ... declarations of dividends are subject to approval of the Board ...
(Date:8/7/2017)... Aug. 7, 2017  Diplomat Pharmacy, Inc. (NYSE: DPLO), the ... quarter ended June 30, 2017.  All comparisons, unless otherwise noted, ... Second Quarter 2017 Highlights include: ... $1,089 million, an increase of 3.5% Total ... Gross margin of 7.5% versus 7.6% ...
Breaking Medicine Technology: